Related Experiment Video
Updated: May 5, 2026

23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.6K
Development and validation of a nomogram superior to CHADS2 and CHA2DS2-VASc models for predicting left atrial
Shikun Sun1, Changsheng Ma1, Ying Li2
1Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Journal of Thoracic Disease
|April 15, 2024
Summary
This study developed a novel nomogram to predict left atrial appendage thrombus in atrial fibrillation patients, outperforming existing risk scores. The model identifies high-risk individuals for stroke, improving clinical decision-making.
Area of Science:
- Cardiology
- Medical Imaging
- Predictive Modeling
Background:
- Atrial fibrillation (AF) is a common arrhythmia with stroke as its critical complication, often caused by left atrial appendage thrombus (LAAT).
- Accurate identification of patients at high risk for LAAT is crucial for stroke prevention.
Purpose of the Study:
- To construct and validate a nomogram model for predicting left atrial appendage (LAA) dense spontaneous echo contrast (SEC) and LAAT.
- To compare the predictive performance of the novel nomogram against established risk stratification models (CHADS₂ and CHA₂DS₂-VASc).
Main Methods:
- A retrospective analysis of 433 AF patients who underwent transesophageal echocardiography (TEE).
- Logistic regression was used to identify independent predictors for LAA dense SEC/LAAT.
- A nomogram was constructed and its performance evaluated using consistency, receiver operating characteristic (ROC), and decision curve analyses.
Main Results:
- Female gender, elevated D-dimer, reduced left ventricular ejection fraction, reduced left atrial ejection fraction, and decreased left atrial reservoir strain rate were significant predictors of LAA dense SEC/LAAT.
- The developed nomogram demonstrated high consistency (0.921) and calibrated consistency (0.903).
- The nomogram significantly outperformed the CHADS₂ and CHA₂DS₂-VASc models in predicting LAA dense SEC/LAAT, showing superior net reclassification and integrated discrimination improvements.
Conclusions:
- The novel nomogram offers excellent performance in predicting LAA dense SEC/LAAT in AF patients.
- This tool provides a superior alternative to the CHADS₂ and CHA₂DS₂-VASc models for identifying high-risk individuals.
- The nomogram can aid clinicians in more accurate stroke risk stratification and management for AF patients.

